Bone Marrow Transplant Rejection Treatment Market Sluggish Growth Rate Foreseen by 2023-2029
Bone marrow transplant rejection treatment market is anticipated to grow at a significant CAGR during the forecast period. Bone marrow transplantation is a therapy to replace diseased bone marrow cells with healthy ones from a donor and it is done through either blood stem cells or by donating certain specific types of white blood cells. However, the rejection occurs when the transplanted immune system fails to accept the donated tissue. It is also known as graft-versus-host disease (GVHD). The major factor contributing to the growth of the global bone marrow transplant rejection treatment market is the increasing demand for better treatment options with minimal side effects across the globe.
Moreover, the market is also
growing due to the increasing prevalence of leukemia and lymphoma globally.
According to the Leukemia and Lymphoma Society, every 3 minutes, one person is
diagnosed with leukemia, lymphoma or myeloma in the US. Additionally, in 2021,
an estimated 186,400 people are anticipated to be diagnosed with leukemia,
lymphoma or myeloma in the US. Furthermore, in 2021 new cases of leukemia,
lymphoma and myeloma are anticipated to account for 9.8% of the estimated 1,898,160
new cancer cases that will be diagnosed in the US.
Some major key players in the
market include Merck & Co., Inc., and Bristol-Myers Squibb Co., among
others. The market players are contributing significantly to the growth of the
market by the adoption of various strategies including mergers &
acquisitions, geographical expansion, partnerships and collaborations, and new
product launches, to stay competitive in the market. For instance, in December
2021, The US FDA approved Bristol Myers Squibb’s Orencia (abatacept) for the
prophylaxis (prevention) of acute graft versus host disease (aGVHD). Orencia
originally approved by the FDA in 2005 for treating adult rheumatoid arthritis
and also approved for treating polyarticular juvenile idiopathic arthritis and
adult psoriatic arthritis. It may now be used in adults and pediatric patients
two years of age or older undergoing hematopoietic stem cell transplantation
(commonly known as bone marrow transplantation or stem cell transplantation)
from an unrelated donor.
To Request a Sample of our Report on Bone Marrow
Transplant Rejection Treatment Market: https://www.omrglobal.com/request-sample/bone-marrow-transplant-rejection-treatment-market
Market Coverage
·
The market number available for – 2021-2029
·
Base year- 2021
·
Forecast period- 2023-2029
Segment Covered-
·
By Product Type
·
By Application
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape- Merck & Co., Inc., and
Bristol-Myers Squibb Co., among others.
Bone Marrow Transplant Rejection Treatment Market Report
by Segment
By Type
• Azathioprine
• Adrenocorticotropic Hormone
• Cyclophosphamide
• Cyclosporine A
• Others
By Application
• Clinic
• Hospital
• Others
A
full Report of Bone Marrow Transplant Rejection Treatment Market is Available
@ https://www.omrglobal.com/industry-reports/bone-marrow-transplant-rejection-treatment-market
Bone Marrow Transplant Rejection Treatment Market Report
by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment